Sign in

CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Pelthos Therapeutics Inc.

Sign in to watch
Ticker
PTHS
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
863335449
Phone
919-908-2422
Business address
4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
Former names
Channel Therapeutics Corp, Chromocell Therapeutics Corp
  1. 4 Option exercise Director acquired 20,641 shares (option exercise)
  2. 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Other events
  3. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  4. 424B4 Offering Prospectus
  5. 424B4 Offering Prospectus
  6. POS EX Other Post-effective Amendment
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. CERT Other Certification
  18. 8-A12B Other Registration of Securities
  19. EFFECT Other Notice of Effectiveness
  20. S-1/A Offering Registration Statement

Page 11 of 13 · 259 filings